- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Structure and inhibition of the human lysosomal transporter Sialin ; volume:15 ; number:1 ; day:23 ; month:5 ; year:2024 ; pages:1-11 ; date:12.2024
Nature Communications ; 15, Heft 1 (23.5.2024), 1-11, 12.2024
- Urheber
-
Schmiege, Philip
Donnelly, Linda
Elghobashi-Meinhardt, Nadia
Lee, Chia-Hsueh
Li, Xiaochun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-48535-3
- URN
-
urn:nbn:de:101:1-2408020924583.434624079010
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schmiege, Philip
- Donnelly, Linda
- Elghobashi-Meinhardt, Nadia
- Lee, Chia-Hsueh
- Li, Xiaochun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Structure of the human dopamine transporter and mechanisms of inhibition
An inventory of lysosomal ABC transporters
A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin
Functional reconstitution of the human lysosomal peptide transporter TAPL reveals the substrate specificity
Regulation of lysosomal ion homeostasis by channels and transporters
Inhibition of endo-lysosomal function exacerbates vascular calcification
Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters
Structural and functional characterization of the lysosomal peptide transporter TAPL
Characterization of the lysosomal targeting of the ABC transporter TAPL
Structure of human drug transporters OATP1B1 and OATP1B3
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
Structure of the human dopamine transporter and mechanisms of inhibition
An inventory of lysosomal ABC transporters
A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin
Functional reconstitution of the human lysosomal peptide transporter TAPL reveals the substrate specificity
Regulation of lysosomal ion homeostasis by channels and transporters
Inhibition of endo-lysosomal function exacerbates vascular calcification
Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters
Structural and functional characterization of the lysosomal peptide transporter TAPL
Characterization of the lysosomal targeting of the ABC transporter TAPL
Structure of human drug transporters OATP1B1 and OATP1B3
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
Structure of the human dopamine transporter and mechanisms of inhibition
An inventory of lysosomal ABC transporters
A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin
Functional reconstitution of the human lysosomal peptide transporter TAPL reveals the substrate specificity
Regulation of lysosomal ion homeostasis by channels and transporters
Inhibition of endo-lysosomal function exacerbates vascular calcification
Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters
Structural and functional characterization of the lysosomal peptide transporter TAPL
Characterization of the lysosomal targeting of the ABC transporter TAPL
Structure of human drug transporters OATP1B1 and OATP1B3
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer